2D QSAR and similarity studies on cruzain inhibitors aimed at improving selectivity over cathepsin L

Bioorganic and Medicinal Chemistry

Volumn 16, Issue 2, 2008, Pages 838-853

  Freitas, Renato F ^a   Oprea, Tudor I ^b   Montanari, Carlos A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Cathepsin L; Chagas' disease; Cruzain; HQSAR; ROCS

Indexed keywords

ANTIPROTOZOAL AGENT; CATHEPSIN L; CRUZIPAIN; CYSTEINE PROTEINASE INHIBITOR;

ANTIPROTOZOAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; ATOM; CHEMICAL BOND; DATA BASE; DRUG ACTIVITY; DRUG POTENCY; DRUG SCREENING; DRUG SELECTIVITY; DRUG STRUCTURE; HOLOGRAPHY; MODEL; MOLECULAR MODEL; MOLECULE; NONHUMAN; NORMAL DISTRIBUTION; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; ROC CURVE; SEQUENCE HOMOLOGY; TRYPANOSOMA CRUZI;

ANIMALS; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; PROTOZOAN PROTEINS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOSOMA CRUZI;

MAMMALIA; TRYPANOSOMA CRUZI;

EID: 38749090154     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.10.048     Document Type: Article

References (31)

1. Nwaka S., and Hudson A. Nat. Rev. Drug Discov. 5 (2006) 941
2. Croft S.L., Barrett M.P., and Urbina J.A. Trends Parasitol. 21 (2005) 508
3. Barrett M.P., Burchmore R.J.S., Stich A., Lazzari J.O., Frasch A.C., Cazzulo J.J., and Krishna S. The Lancet 362 (2003) 1469
4. Maya J.D., Cassels B.K., Vasques P.I., Ferreira J., Faúndez M., Galanti N., Ferreira A., and Morrelo A. Comp. Biochem. Physiol. A: Physiol. 146 (2007) 601
5. Linares G.E.G., Ravaschino E.L., and Rodriguez J.B. Cur. Med. Chem. 13 (2006) 335
6. Urbina J.A. Expert Opin. Ther. Patents 13 (2003) 661
7. McKerrow J.H., Engel J.C., and Caffrey C.R. J. Exp. Med. 7 (1999) 639
8. Polticelli F., Zaini G., Bolli A., Antonini G., Gradoni L., and Ascenzi P. Biochemistry 44 (2005) 2781
9. Waterbeemd H., and Gifford E. Nat. Rev. Drug Discov. 2 (2003) 192
10. Kubinyi H. Drug Discov. Today 2 (1997) 538
11. Sutherland J.J., O'Brien L.A., and Weaver D.F. J. Med. Chem. 47 (2004) 5541
12. Huang L., Lee A., and Ellman J.A. J. Med. Chem. 45 (2002) 676
13. Tong W., Lowis D.R., Perkins R., Chen Y., Welsh W.J., Goddette D.W., Heritage T.W., and Sheehan D.M. J. Chem. Inf. Comput. Sci. 38 (1998) 669
14. Talafous J. Drug Discov. Today 10 (2005) 737
15. Olah M., Mracec M., Ostopovici L., Rad R., Bora A., Hadaruga N., Olah I., Banda M., Simon Z., Mracec M., and Oprea T.I. WOMBAT: World of Molecular Bioactivity. In: Oprea T. (Ed). Chemoinformatics in Drug Discovery (2004), Wiley-VHC, New York 223-239
16. Greenwood B.J., and Gottfries J. J. Mol. Graph. Model 21 (2003) 449
17. Rush III T.S., Grant J.A., Mosyak L., and Nicholls A. J. Med. Chem. 48 (2005) 1489
18. Cramer III R.D., Patterson D.E., and Bunce J. J. Am. Chem. Soc. 110 (1988) 5959
19. HCA™ Manual, SYBYL 7.3, Tripos, St. Louis, MO.
20. Stoyanov K., and Walmsley A.D. Classification and Pattern Recognition. In: Gemperline P.J. (Ed). Practical Guide to Chemometrics (2006), CRC-Taylor and Francis, Oxford 347-351
21. Jain A.N. J. Med. Chem. 47 (2004) 947
22. HQSAR™ Manual, SYBYL 7.3, Tripos, St. Louis, MO.
23. Surflex Manual: Docking and Similarity, BioPharmics LLC, San Mateo, CA.
24. Golbraikh A., and Tropsha A. Mol. Diversity 5 (2000) 231
25. Lecaille F., Authié E., Moreau T., Serveau C., Gauthier F., and Lalmanach G. Eur. J. Biochem. 268 (2001) 2733
26. http://www.ebi.ac.uk/emboss/align/index.html. Query carried on 06/20/2007.
27. Abdulla M.H., Lim K.C., Sajid M., McKerrow J.H., and Caffrey C.R. PLoS Med. 4 (2007) 130
28. Huanga L., Brinen L.S., and Ellman J.A. Bioorg. Med. Chem. 11 (2003) 21
29. Boström J., Greenwood J.R., and Gottfries J. J. Mol. Graphics Modell. 21 (2003) 449
30. Triballeau N., Acher F., Brabet I., Pin J.P., and Bertrand H.O. J. Med. Chem. 48 (2005) 2534
31. Haigh J.A., Pickup B.T., Grant J.A., and Nicholls A. J. Chem. Inf. Model 45 (2005) 673